首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Prospective Multicenter Study of the Epidemiology Molecular Identification and Antifungal Susceptibility of Candida parapsilosis Candida orthopsilosis and Candida metapsilosis Isolated from Patients with Candidemia
【2h】

Prospective Multicenter Study of the Epidemiology Molecular Identification and Antifungal Susceptibility of Candida parapsilosis Candida orthopsilosis and Candida metapsilosis Isolated from Patients with Candidemia

机译:从念珠菌血症患者中分离到的副念珠菌正念珠菌和间念珠菌流行病学分子鉴定和抗真菌药性的多中心前瞻性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 13-month prospective multicenter study including 44 hospitals was carried out to evaluate the epidemiology of Candida parapsilosis complex candidemia in Spain. Susceptibility to amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole, posaconazole, anidulafungin, caspofungin, and micafungin was tested by the microdilution colorimetric method. A total of 364 C. parapsilosis complex isolates were identified by molecular methods: C. parapsilosis (90.7%), Candida orthopsilosis (8.2%), and Candida metapsilosis (1.1%). Most candidemias (C. parapsilosis, 76.4%; C. orthopsilosis, 70.0%; C. metapsilosis, 100%) were observed in adults. No C. orthopsilosis or C. metapsilosis candidemias occurred in neonates. C. parapsilosis was most frequent in adult intensive care unit (28.8%), surgery (20.9%), and internal medicine (19.7%) departments; and C. orthopsilosis was most frequent in hematology (28.6%), pediatrics (12.0%), and neonatology (11.5%) departments. The geographic distribution of C. orthopsilosis and C. metapsilosis was not uniform. According to CLSI clinical breakpoints, all C. orthopsilosis and C. metapsilosis isolates were susceptible to the nine agents tested. Resistance (MICs > 1 mg/liter) was observed only in C. parapsilosis: amphotericin B, posaconazole, itraconazole, and caspofungin (0.3% each), anidulafungin (1.9%), and micafungin (2.5%). Applying the new species-specific fluconazole and echinocandin breakpoints, the rates of resistance to fluconazole for C. parapsilosis and C. orthopsilosis increased to 4.8% and 0.3%, respectively; conversely, for C. parapsilosis they shifted from 1.9 to 0.6% (anidulafungin) and from 2.5 to 0.6% (micafungin). Our study confirms the different prevalence of C. parapsilosis complex candidemia among age groups: neither C. orthopsilosis nor C. metapsilosis was isolated from neonates; interestingly, C. metapsilosis was isolated only from adults and the elderly. The disparity in antifungal susceptibility among species could be important for therapy.
机译:进行了一项为期13个月的前瞻性多中心研究,包括44家医院,以评估西班牙念珠菌假丝酵母复合念珠菌病的流行病学。通过微量稀释比色法测试了对两性霉素B,氟胞嘧啶,氟康唑,伊曲康唑,伏立康唑,泊沙康唑,阿尼芬净,卡泊芬净和米卡芬净的敏感性。通过分子方法鉴定出总共364份副寄生念珠菌复合体:副寄生念珠菌(90.7%),假丝酵母​​(8.2%)和假丝酵母(1.1%)。在成年人中观察到大多数念珠菌病(副念珠菌为76.4%;正念珠菌为70.0%;间位念珠菌为100%)。新生儿未发生直立弯曲杆菌或C. metapsilosis念珠菌病。成人重症监护病房(28.8%),外科手术(20.9%)和内科(19.7%)部门中,C。parapsilosis最常见;在血液科(28.6%),儿科(12.0%)和新生儿科(11.5%)中,角膜弯曲杆菌和角膜弯曲杆菌最常见。直立弯曲杆菌和间位弯曲菌的地理分布不均匀。根据CLSI的临床断点,所有直立弯曲梭菌和间皮梭状芽胞杆菌分离株均易受9种药物的影响。仅在 C中观察到抗药性(MICs> 1 mg / L)。副瘫痪:两性霉素B,泊沙康唑,伊曲康唑和卡泊芬净(各占0.3%),阿尼芬净(1.9%)和米卡芬净(2.5%)。应用新的物种特有的氟康唑和棘皮菌素断点,可得出 C对氟康唑的耐药率。 C。骨化症分别增加到4.8%和0.3%;相反,对于 C。副滑石症的发生率从1.9%降至0.6%(阿米芬净)和2.5%至0.6%(米卡芬净)。我们的研究证实了 C的不同流行。年龄段的复杂性念珠菌病:均未出现。骨盆病 C。从新生儿中分离出metapsilosis 。有趣的是, C。仅发生于成年人和老年人。物种之间抗真菌药敏性的差异可能对治疗很重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号